Clostridioides difficile strain WCH065050 115

Clostridioides difficile strain WCH065050 115 is a Gram-positive, anaerobic, mesophilic rod that exhibits mobility through the presence of flagella. This strain is a chemoorganotroph, deriving its energy from organic compounds, and typically grows in chains, pairs, or as singles. Its optimal growth temperature is 37°C, aligning with the typical body temperature of its primary hosts. This strain is associated with several hosts, including Homo sapiens (humans), Gallus gallus (chickens), Metazoa, Sus scrofa (pigs), Canis lupus familiaris (domestic dogs), and Felis catus (domestic cats), indicating a broad ecological adaptability. As a free-living organism, C. difficile can thrive in diverse environments, particularly within the gastrointestinal tracts of these hosts. Clostridioides difficile strain WCH065050 115 is notably pathogenic in humans, causing a range of health effects including diarrhea, colitis, and severe gastrointestinal conditions such as pseudomembranous colitis and toxic megacolon. It is well-known for its role in healthcare-associated infections, particularly in hospital settings, where it can lead to antibiotic-associated diarrhea and persistent infections. Given its pathogenic potential and association with various hosts, the presence of this strain in healthcare settings underscores the importance of monitoring and managing antibiotic use to mitigate the risk of C. difficile infections. This highlights the ecological interplay between antibiotic use in humans and the emergence of resistant strains in different host species.